MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Foamix Pharmaceuticals Ltd Company Profile (NASDAQ:FOMX)

Consensus Ratings for Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (42.86% upside)

Analysts' Ratings History for Foamix Pharmaceuticals Ltd (NASDAQ:FOMX)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2016GuggenheimReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015BarclaysBoost Price TargetOverweight$11.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014MacquarieInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014Maxim GroupInitiated CoverageHold$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Cowen and CompanyInitiated CoverageOutperform$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014OppenheimerInitiated CoverageOutperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha